Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Twitter
Cryptocurrency
Sensex
Inflation
Stock Market
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Business News / Lupin will bring new class of diabetes drugs to India
Business

Lupin will bring new class of diabetes drugs to India

Lupin will bring new class of diabetes drugs to India
Written by Anish Chakraborty
Sep 13, 2017, 12:25 am 2 min read
Lupin will bring new class of diabetes drugs to India

Pharma major Lupin Ltd intends to bolster its diabetes drugs offering in the Indian market by introducing a new class of drugs in its portfolio via the in-licensing route. In-licensing allows firms to market the products of another firm in one or more locations. Lupin's current diabetes drugs' basket doesn't have GLP 1 analog, which it wants to bring through this route. Here's more.

GLP 1
What's the drug?

GLP 1 or glucagon-like peptide-1 receptor agonist is used to normalize blood sugar levels. In India, the drug is sold by Novo Nordisk, Eli Lily and Co. and Sanofi, in injectable form. Novo Nordisk sells it via Abbott India, under the brand name Victoza. Eli Lily and Sanofi sell it under the brand names Victoza and Lyxumia respectively. It costs around Rs. 3,100-4,000.

In-licensing
In-licensing is key to Lupin's growth

Lupin currently holds 4.24% market share in India's Rs. 10,534 crore diabetes drugs market. Lupin's diabetes drugs' portfolio saw a 36% growth in the year that ended in July, against the 17% growth witnessed by the domestic diabetes market. Lupin's President of India, Region Formulations, Rajeev Sibal said to Mint, in-licensing of drugs will be a key aspect of the firm's Indian business strategy.

Pharma
Lupin's hold over India's pharma market

Sibal said, "Lupin has been one of the most successful companies when alliances are concerned. We have almost 15 alliances, which has helped us grow." During the last five years, Lupin's domestic business grew at 15% CAGR, eclipsing the 12% average industry growth. India makes for 22% of Lupin's total revenue and it's the sixth largest pharma company in terms of domestic market presence.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Anish Chakraborty
Anish Chakraborty
Mail
“Do not go gentle into that good night” Calcutta University, drinks coffee, owns a fountain pen, knows how to write about things lucidly.
Latest
India
Medicine
Lupin Ltd
Latest
5 Lebanese dishes you must try
5 Lebanese dishes you must try Lifestyle
Supreme Court refuses to postpone NEET-PG 2022 exam
Supreme Court refuses to postpone NEET-PG 2022 exam India
Italian Open: Djokovic marches into quarters; Shapovalov downs Nadal
Italian Open: Djokovic marches into quarters; Shapovalov downs Nadal Sports
Jammu and Kashmir: Terrorists gun down police constable in Pulwama
Jammu and Kashmir: Terrorists gun down police constable in Pulwama India
Premier League 2021-22: Kane, Son help Tottenham sink Arsenal 3-0
Premier League 2021-22: Kane, Son help Tottenham sink Arsenal 3-0 Sports
India
Late Danish Siddiqui awarded 2nd Pulitzer for photographing COVID-19 deaths
Late Danish Siddiqui awarded 2nd Pulitzer for photographing COVID-19 deaths World
WHO report claims India underreported COVID-19 deaths; India strongly objects
WHO report claims India underreported COVID-19 deaths; India strongly objects India
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon India
COVID-19: India reports 2,568 new cases, 20 more deaths
COVID-19: India reports 2,568 new cases, 20 more deaths India
Majority of India's workforce has stopped looking for jobs: Report
Majority of India's workforce has stopped looking for jobs: Report India
More News
Medicine
World Homeopathy Day 2022: History, benefits, and more
World Homeopathy Day 2022: History, benefits, and more Lifestyle
Hetero seeks Emergency Use Authorization for Molnupiravir in India
Hetero seeks Emergency Use Authorization for Molnupiravir in India India
#WeeklyRecap: Nobel Prizes, Pixel 4a, Galaxy S20 FE, and more
#WeeklyRecap: Nobel Prizes, Pixel 4a, Galaxy S20 FE, and more Technology
Nobel Prize: Three scientists win for 'discovering Hepatitis C virus'
Nobel Prize: Three scientists win for 'discovering Hepatitis C virus' Technology
Patanjali CEO claims cure for COVID-19 possible through Ayurveda
Patanjali CEO claims cure for COVID-19 possible through Ayurveda India
More News
Lupin Ltd
Netflix's 'Lupin' part 2 new trailer: Gentleman thief is back
Netflix's 'Lupin' part 2 new trailer: Gentleman thief is back Entertainment
'Lupin' to face Sherlock Holmes? Show creator talks of 'discussions'
'Lupin' to face Sherlock Holmes? Show creator talks of 'discussions' Entertainment
More News
Next News Article
Next News Article

Love Business news?

Subscribe to stay updated.

Business Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022